Eisler Capital (UK)’s Zura Bio Limited Warrants ZURAW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-100,000
Closed -$13.8K 296
2022
Q4
$13.8K Hold
100,000
﹤0.01% 94
2022
Q3
$16K Hold
100,000
﹤0.01% 194
2022
Q2
$18K Buy
+100,000
New +$27.1K ﹤0.01% 336

Other funds holding ZURAW

Eisler Capital (UK)'s ZURAW Position: Q1 2023 in Review

Eisler Capital (UK) sold out of Zura Bio Limited Warrants (ZURAW) in Q1 2023, closing a stake of 100,000 shares — an estimated $13.8K sold.

Eisler Capital (UK) first reported a position in ZURAW in Q2 2022 and held it in 3 quarters. The position peaked at $18K in Q2 2022. 16 funds tracked by Wall St. Rank hold ZURAW as of Q1 2023.

  • Eisler Capital (UK) reported no remaining Zura Bio Limited Warrants position as of Q1 2023 after selling out during the quarter.
  • Eisler Capital (UK) sold 100,000 Zura Bio Limited Warrants shares in Q1 2023, an estimated $13.8K.
  • Eisler Capital (UK) first reported a position in Zura Bio Limited Warrants in Q2 2022 and held it in 3 quarters.
  • Eisler Capital (UK)'s Zura Bio Limited Warrants position peaked at $18K in Q2 2022.
  • 16 funds tracked by Wall St. Rank held Zura Bio Limited Warrants as of Q1 2023.

Based on Eisler Capital (UK)'s 13F filing for Q1 2023, filed 12 May 2023.